Literature DB >> 1899944

Demographic characteristics, drug use, and sexual behavior of i.v. drug user with AIDS in Bronx, New York.

L Schrager1, G Friedland, C Feiner, P Kahl.   

Abstract

Intravenous (i.v.) drug users are a key factor in the transmission of human immunodeficiency virus (HIV) infection, yet epidemiologic information about this population, especially those with acquired immunodeficiency syndrome, is scarce. The demographic characteristics, drug use behavior, and sexual practices of i.v. drug users who developed AIDS were prospectively studied at the Montefiore Medical Center from October 1984 to February 1988. The early wave of i.v. drug users with AIDS was characterized by poverty, minority overrepresentation (more than 80 percent were black or Hispanic), and initiation of i.v. drug use at an early age (median age 19 years). Injection of drugs and sharing of needles was frequent. Most had used so-called shooting galleries, but only for a minority of injection episodes. Heroin or cocaine use was almost universal, nearly always accompanied by abuse of another substance, usually alcohol or marijuana. Fewer than a third had ever participated in a methadone maintenance program, but more than 40 percent had been in prison since 1978. All patients had been sexually active, often with partners who were not i.v. drug users. The research suggests a complex interaction existing between high-risk demographic characteristics, drug use practice, and certain types of sexual behavior, all of which contributed to the early spread of HIV infection in this population. Efforts that are directed toward interrupting i.v. drug user-related transmission of HIV need to include consideration of these characteristics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899944      PMCID: PMC1580205     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  9 in total

1.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

Review 2.  The epidemiology of acquired immunodeficiency syndrome among heterosexuals.

Authors:  H W Haverkos; R Edelman
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

3.  AIDS and addiction in New York City.

Authors:  E Drucker
Journal:  Am J Drug Alcohol Abuse       Date:  1986       Impact factor: 3.829

4.  Intravenous drug use and AIDS prevention.

Authors:  C R Schuster
Journal:  Public Health Rep       Date:  1988 May-Jun       Impact factor: 2.792

5.  The provision and financing of medical care for AIDS patients in US public and private teaching hospitals.

Authors:  D P Andrulis; V S Beers; J D Bentley; L S Gage
Journal:  JAMA       Date:  1987-09-11       Impact factor: 56.272

Review 6.  HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention.

Authors:  D C Des Jarlais; S R Friedman; R L Stoneburner
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

7.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

8.  Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.

Authors:  M Marmor; D C Des Jarlais; H Cohen; S R Friedman; S T Beatrice; N Dubin; W el-Sadr; D Mildvan; S Yancovitz; U Mathur
Journal:  AIDS       Date:  1987-05       Impact factor: 4.177

Review 9.  Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.

Authors:  P W Brickner; R A Torres; M Barnes; R G Newman; D C Des Jarlais; D P Whalen; D E Rogers
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

  9 in total
  3 in total

1.  Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.

Authors:  F Lamothe; J Bruneau; R Coates; J G Rankin; J Soto; R Arshinoff; M Brabant; J Vincelette; M Fauvel
Journal:  CMAJ       Date:  1993-10-01       Impact factor: 8.262

2.  The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention.

Authors:  T Diaz; S Y Chu; R H Byers; B S Hersh; L Conti; C A Rietmeijer; E Mokotoff; S A Fann; D Boyd; L Iglesias
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

3.  Use of web-based shared medical records among patients with HIV.

Authors:  James D Ralston; Michael J Silverberg; Louis Grothaus; Wendy A Leyden; Tyler Ross; Christine Stewart; Steven Carzasty; Michael Horberg; Sheryl L Catz
Journal:  Am J Manag Care       Date:  2013-04-01       Impact factor: 2.229

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.